REGULAR CONTENT
Final ID
413
Type
Original Scientific Research-Poster Only
Authors
G Kim1, K Joon Ho1, M Kim1, J Won1, S Park1, K Han1, H Jae2, D Lee1
Institutions
1Severance Hospital, Yonsei University College of Medicine, Seoul, Seodaemun-gu, 2Seoul National University Hospital, Seoul, Korea, Republic of
Purpose
To explore the imaging findings and clinical results of uterine artery embolization (UAE) for the treatment of ectopic pregnancy.
Materials & Methods
Since December 2006, twelve patients with ectopic pregnancy underwent uterine artery embolization combined with methotrexate in our institution. We retrospectively reviewed their ultrasonographic and angiographic findings, embolization and methotrexate (MTX) treatment protocols, and clinical results including the change of human chorionic gonadotropin (hCG) and rebleeding rate.
Results
Mean age of the patients was 35.2 (range, 28-41) years and mean gestational age was 8+2 (range, 3+1 - 12+1) weeks. Diagnoses were cervical pregnancy in six, caesarian section scar pregnancy in four, tubal and corneal pregnancy in one each. Mean size of gestational sac was 42.2mm on ultrasonography. Fetal heart beat was seen on transvaginal ultrasonography in one patient. On angiography, stain of gestational sac was seen in three patients (25%), and contrast extravasation was seen in three patients (25%). Unilateral uterine artery was embolized in 3 patients, whereas bilateral uterine arteries were embolized in 9 patients. Used embolic materials were gelatin sponge particles in seven, polyvinyl alcohol in two, and combination of these two materials in two. Nine patients received systemic MTX and the other three underwent intracervical MTX treatment. Mean Serum hCG levels showed 97% (range, 83.0 – 99.9) drop within 1 months. Rebleeding after embolization occurred in three (25%), and the bleeding ceased after secondary embolization in all the rebleeding cases. There was no major procedure-related complication.
Conclusions
UAE combined with MTX is a safe and effective modality for the treatment of ectopic pregnancy.
Final ID
413
Type
Original Scientific Research-Poster Only
Authors
G Kim1, K Joon Ho1, M Kim1, J Won1, S Park1, K Han1, H Jae2, D Lee1
Institutions
1Severance Hospital, Yonsei University College of Medicine, Seoul, Seodaemun-gu, 2Seoul National University Hospital, Seoul, Korea, Republic of
Purpose
To explore the imaging findings and clinical results of uterine artery embolization (UAE) for the treatment of ectopic pregnancy.
Materials & Methods
Since December 2006, twelve patients with ectopic pregnancy underwent uterine artery embolization combined with methotrexate in our institution. We retrospectively reviewed their ultrasonographic and angiographic findings, embolization and methotrexate (MTX) treatment protocols, and clinical results including the change of human chorionic gonadotropin (hCG) and rebleeding rate.
Results
Mean age of the patients was 35.2 (range, 28-41) years and mean gestational age was 8+2 (range, 3+1 - 12+1) weeks. Diagnoses were cervical pregnancy in six, caesarian section scar pregnancy in four, tubal and corneal pregnancy in one each. Mean size of gestational sac was 42.2mm on ultrasonography. Fetal heart beat was seen on transvaginal ultrasonography in one patient. On angiography, stain of gestational sac was seen in three patients (25%), and contrast extravasation was seen in three patients (25%). Unilateral uterine artery was embolized in 3 patients, whereas bilateral uterine arteries were embolized in 9 patients. Used embolic materials were gelatin sponge particles in seven, polyvinyl alcohol in two, and combination of these two materials in two. Nine patients received systemic MTX and the other three underwent intracervical MTX treatment. Mean Serum hCG levels showed 97% (range, 83.0 – 99.9) drop within 1 months. Rebleeding after embolization occurred in three (25%), and the bleeding ceased after secondary embolization in all the rebleeding cases. There was no major procedure-related complication.
Conclusions
UAE combined with MTX is a safe and effective modality for the treatment of ectopic pregnancy.